Status:
COMPLETED
LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)
Lead Sponsor:
Spanish Lung Cancer Group
Conditions:
Covid-19
Lung Cancer
Eligibility:
All Genders
Brief Summary
This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers...
Eligibility Criteria
Inclusion
- Patients diagnosed with lung cancer
- Patients who have contracted COVID-19 infection
Exclusion
- Patients diagnosed with lung cancer but no confirmation of COVID-19 infection.
Key Trial Info
Start Date :
April 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 6 2021
Estimated Enrollment :
886 Patients enrolled
Trial Details
Trial ID
NCT04344002
Start Date
April 21 2020
End Date
October 6 2021
Last Update
June 27 2022
Active Locations (75)
Enter a location and click search to find clinical trials sorted by distance.
1
Complejo Hospitalario Universitario de Ferrol
Ferrol, A Coruña, Spain
2
H. Clínica Benidorm
Benidorm, Alicante, Spain, 03501
3
Hospital de Elche
Elche, Alicante, Spain, 03202
4
Hospital General Universitario de Elda
Elda, Alicante, Spain, 03600